Considerations for improving future pandemic responses DOI Open Access
Mikolaj Raszek, David E. Cowley,

Rubio-Casillas Alberto

et al.

Journal of Vaccines and Immunology, Journal Year: 2023, Volume and Issue: 10(1), P. 001 - 005

Published: Feb. 8, 2023

The COVID-19 pandemic of 2020 shook the world with its unprecedented scale, affecting over 700 million people and causing nearly 7 deaths globally. In response, rapid extraordinary measures were taken, including development distribution vaccines at an pace. However, speed magnitude response have raised questions about efficacy ethics certain measures. To address these concerns, we present a non-comprehensive list contentious issues that merit discussion investigation by scientific medical communities. These encompass public education, ethical considerations, legal implications, policy decisions, regulatory oversight, gaps in knowledge, concerns related to mass vaccination efforts. By examining topics, aim improve future crisis responses maintain trust participation programs. It is essential learn from successes shortcomings better prepare for health crises ensure safety well-being communities worldwide.

Language: Английский

Excess mortality during the first two years of the COVID-19 epidemic (2020-2021) in the Netherlands: overall and across demographic subgroups DOI Creative Commons
Camila Caram‐Deelder, Astrid van Hylckama Vlieg, Rolf H. H. Groenwold

et al.

IJID Regions, Journal Year: 2024, Volume and Issue: 14, P. 100500 - 100500

Published: Nov. 27, 2024

The overall impact of the COVID-19 pandemic on mortality can be estimated by assessment excess deaths from all causes because reported number due to do not accurately reflect true death toll. We assessed in 2020 and 2021 Netherlands. All analyses were performed data comprehensive nationwide registers provided Statistics Netherlands (Centraal Bureau voor de Statistiek), including demographic characteristics mortality. All-cause incidence rates calculated per calendar month compared against infections preventive strategies. all-cause rate ratios (IRRs) with 95% confidence intervals (95% CIs) year using Poisson regression (overall for subgroups). Compared predicted based 2019 rates, was 8.9% (IRR 1.089, CI 1.081-1.097) 8.5% 1.085, 1.077-1.092) 2021. Relative higher men, people low household income, first-generation immigrants, individuals living extremely urbanized areas. In 2020, highest age groups above 75 years (over 10%.); 2021, it clearly present even 20-39 group (6.6%). Our results quantify during first 2 show that extent varies considerably across groups, which may help identifying target strategies future health crises.

Language: Английский

Citations

0

Relationship between COVID-19 cases and monthly mortality from all causes, cancer, cardiovascular diseases and diabetes in 16 countries, 2020–21 DOI

Margherita Pizzato,

Claudia Santucci, Nazrul Islam

et al.

International Journal of Epidemiology, Journal Year: 2024, Volume and Issue: 54(1)

Published: Dec. 16, 2024

Abstract Background During the COVID-19 pandemic, mortality from some chronic diseases increased. In this study, we evaluated monthly excess all causes, cancer, cardiovascular (CVD) and diabetes during months of 2020 2021, examining its relationship with cases. Methods Monthly cause-specific data were downloaded public repositories national statistics offices or directly requested them, population obtained United Nations archives. Excess deaths estimated as difference between observed expected deaths. for 2021 calculated using a quasi-Poisson regression model trained on 2010–19 (or shorter timespan if full decade was not available). To quantify correlation cases mortality, used Spearman’s coefficient (rs). Results The study included 16 countries that provided causes death (Argentina, Austria, Brazil, Switzerland, Chile, Czech Republic, Germany, Georgia, Hungary, Italy, Lithuania, Latvia, Mexico, Serbia, Slovakia USA). A positive found in (rs ranging 0.61 to 0.91), CVD 11 0.45 0.85) 13 0.42 0.79). above 5% 14 both seven nine 12 2021. No cancer any considered. Conclusions persisted several throughout These increases coincide peaks, supporting short-term impact pandemic these causes.

Language: Английский

Citations

0

When Claims of ‘Revisionism’ and ‘Misinformation’ are Themselves Misinformed: Implications for Policy Decision-Making DOI Open Access
Ari R. Joffe,

Pooya Kazemi,

Roy Eappen

et al.

Published: Oct. 19, 2023

A recent publication defined lockdown “revisionism” as “the spread of misinformation on lockdowns and other public health measures.” We used this to analyze the claim that questioning or interventions mandates amounts “misinformation”. suggest term ‘revisionism’, like ‘misinformation’ contained in its definition, were merely labels denigrate evidence-based contrary conclusions so avoid having critically appraise best evidence itself. aim describe how, by glossing over topics without fully engaging with available, assertions made do not withstand critical scrutiny. that, ensure lessons are learned for future, we must be willing engage rigorous open debate – calling reasonable scrutiny ‘misinformation’, ‘disinformation’, ‘revisionism’ is supportive goal. Finally, a main lesson from COVID-19 pandemic have an increased focus so-called but rather re-discover emergency management process making decisions multidisciplinary representation, transparency, cost-benefit analyses courses using protects against censorship groupthink.

Language: Английский

Citations

0

Considerations for improving future pandemic responses DOI Open Access
Mikolaj Raszek, David E. Cowley,

Rubio-Casillas Alberto

et al.

Journal of Vaccines and Immunology, Journal Year: 2023, Volume and Issue: 10(1), P. 001 - 005

Published: Feb. 8, 2023

The COVID-19 pandemic of 2020 shook the world with its unprecedented scale, affecting over 700 million people and causing nearly 7 deaths globally. In response, rapid extraordinary measures were taken, including development distribution vaccines at an pace. However, speed magnitude response have raised questions about efficacy ethics certain measures. To address these concerns, we present a non-comprehensive list contentious issues that merit discussion investigation by scientific medical communities. These encompass public education, ethical considerations, legal implications, policy decisions, regulatory oversight, gaps in knowledge, concerns related to mass vaccination efforts. By examining topics, aim improve future crisis responses maintain trust participation programs. It is essential learn from successes shortcomings better prepare for health crises ensure safety well-being communities worldwide.

Language: Английский

Citations

0